Dabomb Protein Biotech (ROCO:6578) Total Liabilities: NT$106.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6578 Dabomb Protein Biotech Corp ROCO:6578
59 GF Score
Price NT$16.45
GF Value NT$14.48
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Dabomb Protein Biotech Total Liabilities?

Dabomb Protein Biotech ROCO:6578 +7.79% 59 Total Liabilities is NT$106.5 Mil as of Dec. 2025. GuruFocus rates ROCO:6578 with a GF Score™ of 59/100 and a GF Value™ of NT$14.48 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Dabomb Protein Biotech's Total Liabilities for the quarter that ended in Dec. 2025 was NT$106.5 Mil.

Dabomb Protein Biotech's quarterly Total Liabilities declined from Jun. 2025 (NT$198.79 Mil) to Sep. 2025 (NT$164.04 Mil) and declined from Sep. 2025 (NT$164.04 Mil) to Dec. 2025 (NT$106.48 Mil).

Dabomb Protein Biotech's annual Total Liabilities declined from Dec. 2023 (NT$443.83 Mil) to Dec. 2024 (NT$225.96 Mil) and declined from Dec. 2024 (NT$225.96 Mil) to Dec. 2025 (NT$106.48 Mil).

Dabomb Protein Biotech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Dabomb Protein Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dabomb Protein Biotech Total Liabilities Chart

Dabomb Protein Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 662.24 552.88 443.83 225.96 106.48

Dabomb Protein Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 225.96 192.08 198.79 164.04 106.48
ROCO:6578
59GF Score
Dabomb Protein Biotech Corp ROCO:6578
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dabomb Protein Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Dabomb Protein Biotech's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=84.488+(19.513+2.483
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=106.5

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1095.76-989.276
=106.5

Dabomb Protein Biotech's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=84.488+(19.513+2.483
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=106.5

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=1095.76-989.276
=106.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$106.5 Mil mean?
Dabomb Protein Biotech (ROCO:6578) has a Total Liabilities of NT$106.5 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Dabomb Protein Biotech and its competitors.
Is Dabomb Protein Biotech's Total Liabilities too high?
Dabomb Protein Biotech's current Total Liabilities is NT$106.5 Mil. Overall, Dabomb Protein Biotech has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's Total Liabilities compare to KHC and GIS?
Dabomb Protein Biotech's Total Liabilities of NT$106.5 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Dabomb Protein Biotech and its competitors. Dabomb Protein Biotech's current Total Liabilities is NT$106.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$14.48, compared to a current price of NT$16.45 — trading 13.6% above its estimated fair value. The current Total Liabilities is NT$106.5 Mil. Dabomb Protein Biotech's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current Total Liabilities is NT$106.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?

Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be overvalued. The current stock price of NT$16.45 is trading 13.6% above its estimated GF Value™ of NT$14.48. GuruFocus considers Dabomb Protein Biotech to be Modestly Overvalued.

Key valuation signals for ROCO:6578:

  • Total Liabilities: NT$106.5 Mil
  • GF Value™: NT$14.48 vs. price of NT$16.45 (13.6% above fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dabomb Protein Biotech Business Description

Address No. 52, Industrial 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
59GF Score

Get the complete analysis for ROCO:6578

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.45
Price
NT$14.48
GF Value